Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Capital Leases: 2009-2010

Historic Capital Leases for Amicus Therapeutics (FOLD) over the last 2 years, with Dec 2010 value amounting to $40,000.

  • Amicus Therapeutics' Capital Leases fell 86.89% to $40,000 in Q4 2010 from the same period last year, while for Dec 2010 it was $40,000, marking a year-over-year decrease of 86.89%. This contributed to the annual value of $40,000 for FY2010, which is 86.89% down from last year.
  • Per Amicus Therapeutics' latest filing, its Capital Leases stood at $40,000 for FY2010, which was down 86.89% from $305,000 recorded in FY2009.
  • Amicus Therapeutics' 5-year Capital Leases high stood at $305,000 for FY2009, and its period low was $40,000 during FY2010.
  • Its 2-year average for Capital Leases is $172,500, with a median of $172,500 in 2009.
  • Data for Amicus Therapeutics' Capital Leases shows a maximum YoY plummeted of 86.89% (in 2010) over the last 5 years.
  • Yearly analysis of 2 years shows Amicus Therapeutics' Capital Leases stood at $305,000 in 2009, then crashed by 86.89% to $40,000 in 2010.